Location: Ruminant Diseases and Immunology Research
Project Number: 5030-32000-238-005-R
Project Type: Reimbursable Cooperative Agreement
Start Date: Apr 1, 2026
End Date: Sep 21, 2027
Objective:
Developing an effective highly pathogenic avian influenza bovine vaccine, a problem that is highly significant to the dairy industry. Dairy producers in the U.S. lose $950 per affected cow
Approach:
Cooperator will provide cattle that have been intra mammary vaccinated against highly pathogenic avian influenza which ARS with challenge in AG BSL3 to determine vaccine efficacy